DrugPatentWatch Database Preview
Actavis Labs Fl Inc Company Profile
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has seventy-one approved drugs.
There are two tentative approvals on ACTAVIS LABS FL INC drugs.
Summary for Actavis Labs Fl Inc
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 71 |
Drugs and US Patents for Actavis Labs Fl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 206049-001 | May 17, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 077408-003 | Mar 2, 2009 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Actavis Labs Fl Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076172-001 | Jun 16, 2004 | AB1 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | BUDESONIDE | budesonide | TABLET, EXTENDED RELEASE;ORAL | 205457-001 | Jul 3, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091093-002 | Sep 12, 2011 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 203755-002 | Aug 1, 2016 | AB3 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 077298-001 | Apr 15, 2010 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
